SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2021 / Cilt: 25 - Sayı: 6

Kounis syndrome: Is ceftriaxone or metronidazole responsible for acute myocardial infarction? A rare case

Abdülkadir ÇAKMAK
Gökhan KESKİN
Pages
451–452
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report, we present a case of myocardial infarction caused by intravenous (IV) ceftriaxone and IV metronidazole administration.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Kounis syndrome (KS) was first described by Kounis as an allergic angina syndrome progressing to allergic myocardial infarction (1).
📊
Key Findings & Data:Further research about KS revealed that it is a multi-organ and multidisciplinary condition (2).
💡
Conclusion & Impact:In this case report, we present a case of myocardial infarction caused by intravenous (IV) ceftriaxone and IV metronidazole administration.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Kounis syndrome (KS) was first described by Kounis as an allergic angina syndrome progressing to allergic myocardial infarction (1). Further research about KS revealed that it is a multi-organ and multidisciplinary condition (2). In this case report, we present a case of myocardial infarction caused by intravenous (IV) ceftriaxone and IV metronidazole administration.

🔖

Cite This Article

ÇAKMAK, A., KESKİN, G. (2021). Kounis syndrome: Is ceftriaxone or metronidazole responsible for acute myocardial infarction? A rare case. The Anatolian Journal of Cardiology, Cilt: 25 - Sayı: 6, 451–452. https://ajindex.com/articles/365966

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Kounis NG, Zavras GM. Histamine-induced coronary artery spasm: the concept of allergic angina. Br J Clin Pract 1991; 45: 121–8
  2. Kounis NG, Koniari I, Velissaris D, Tzanis G, Hahalis G. Kounis Syndrome-not a Single-organ Arterial Disorder but a Multisystem and Multidisciplinary Disease. Balkan Med J 2019; 36: 212–21. [Crossref] 3. Biteker M. Current understanding of Kounis syndrome. Expert Rev Clin Immunol 2010; 6: 777–88. [Crossref] 4. Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol 2006; 110: 7–14. [Crossref] 5. Matucci, Rossi O, Cecchi L, Vultaggio A, Parronchi P, Brugnolo F, et al. Coronary vasospasm during an acute allergic reaction. Allergy 2002; 57: 867–8. [Crossref] 6. Hasegawa S, Tashiro N, Matsubara T, Furukawa S, Ra C. A comparison of FcepsilonRI-mediated RANTES release from human platelets between allergic patients and healthy individuals. Int Arch Allergy Immunol 2001; 125 Suppl 1: 42–7. [Crossref] 7. Kounis NG. Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management. Clin Chem Lab Med 2016; 54: 1545–59. [Crossref] 8. Biteker M. A new classification of Kounis syndrome. Int J Cardiol 2010; 145: 553. [Crossref] 9. Saleh AA. Kounis syndrome: acute inferior myocardial infarction with atroventricular node block due to ceftriaxone: a first reported case. Ann Saudi Med 2014; 34: 250–3. [Crossref] 10. Terlemez S, Eryılmaz U, Tokgöz Y, Uysal P, Coşan A, Bulut Y. Kounis syndrome caused by metronidazole--a case of 14 year-old boy. Int J Cardiol 2015; 179: 222–4.[Crossref]